StonvexLoading…
StonvexStonvexStonvexCore line items from UDMY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $191.41M | $789.84M | $595.86M | $400.18M |
Operating Income | $-12.53M | $-4.16M | $-726.00K | $-564.00K |
Net Income | $-12.61M | $3.81M | $6.14M | $4.49M |
EPS (Diluted) | $-0.09 | $0.03 | $0.04 | $0.03 |
Total Assets | $634.59M | $617.70M | $618.90M | $643.96M |
Total Liabilities | $422.41M | $407.24M | $397.09M | $410.60M |
Cash & Equivalents | $252.56M | $231.49M | $235.93M | $230.26M |
Free Cash Flow OCF − CapEx | $14.89M | $81.86M | $66.86M | $51.75M |
Shares Outstanding | 145.94M | 145.05M | 147.08M | 149.92M |